The Clinical Presentation of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

Volumn , Issue , 2011, Pages 525-539

  Lahita, Robert G ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874603343     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374994-9.10030-0     Document Type: Chapter

References (149)

1. Stahl J.I., Klippel J.H., Decker J.L. Fever in systemic lupus erythematosus. Am J of Med 1979, 67:933-940.
2. Robb-Nicholson L.C., Liang M.H., Daltroy L., Eaton H., Gall V., Schwartz J., et al. Effects of aerobic conditioning in lupus fatigue: a pilot study. J Rheum 1989, 28:500-505.
3. Dobkin P.L., Da Costa D., Fortin P.R., Edworthy S., Barr S., Esdaile J.M., et al. Living with lupus: a prospective pan-Canadian study. J Rheumatol 2001, 28(11):2442-2448.
4. Godaert G.L., Hartkamp A., Geenen R., Garssen A., Kruize A.A., Bijlsma J.W., et al. Fatigue in daily life in patients with primary Sjogren's syndrome and systemic lupus erythematosus. Ann N Y Acad Sci 2002, 966:320-326.
5. Rovin B.H., Tang Y., Sun J., Nagaraja H.N., Hackshaw K.V., Gray L., et al. Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int 2005, 68(2):747-759.
6. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40(9):1725.
7. Gleicher N. Autoantibodies in normal and abnormal pregnancy. Am J Reprod Immunol 1992, 28:269-273.
8. Parodi A., Rebora A. ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus. Dermatology 1997, 194(3):217-220.
9. Asherson R.A., Cervera R., Lahita R.G. Latent, incomplete or Lupus at all?. J Rheum 1991, 18(12):1783-1786.
10. Gilboe I.M., Husby G. Application of the 1982 revised criteria for the classification of systemic lupus erythematosus on a cohort of 346 Norwegian patients with connective tissue disease. Scand J Rheumatol 1999, 28(2):81-87.
11. Smith E.L., Shmerling R.H. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus 1999, 8(8):586-595.
12. Costenbader K.H., Karlson E.W., Mandl L.A. Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus. J Rheumatol 2002, 29(12):2545-2550.
13. Wilson W.A., Gharavi A., Koike T., Lockshin M.C., Branch D.W., Piette J.C., et al. International Consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 2000, 42(7):1309-1311.
14. W.A. Wilson Classification Crtieria for the Antiphospholipid Syndrome. 3[27], 499-505. 8-1-2001. Philadelphia, W.B. Saunders Co. Rheumatology Clinics of North America. Khamashta, M. A.
15. Estes D., Christian C.L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971, 50:85-95.
16. Dubois E.L. The clinical picture of systemic lupus erythematosus. Lupus Erythematosus 1974, 232-250. University of California Press, Los Angeles. 2nd ed. E.L. Dubois (Ed.).
17. Dubois E.L., Tuiffanelli D.L. Clinical manifestations of systemic lupus erythematosus: computer analysis of 500 cases. JAMA 1964, 190:104-111.
18. Hoffman G.S. Polyarthritis: the differential diagnosis of rheumatoid arthritis. Semin Arthritis Rheum 1978, 8:115-141.
19. Harvey A.M., Shulman L.E., Tumulty P.A. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine 1954, 33:291-437.
20. Alarcon G.S. Arthralgias, myalgias, facial erythema, and a positive ANA: not necessarily SLE. Cleve Clin J Med 1997, 64(7):361-364.
21. Blumenthal D.E. Tired, aching, ANA-positive: does your patient have lupus or fibromyalgia?. Cleve Clin J Med 2002, 69(2). 143-2.
22. Perry S., Miller F. The psychiatric aspects of systemic lupus erythematosus. Systemic Lupus Erythematosus 1992, 845-856. Churchill Livingstone, New York. 2nd ed. R.G. Lahita (Ed.).
23. Cush J.J., Goldings E.A. Drug induced lupus: clinical spectrum and pathogenesis. Am J of Med Sci 1985, 290:36-45.
24. Arnett F.C., Shulman L.E. Studies in familial systemic lupus erythematosus. Medicine 1976, 55:313-322.
25. Honey M. Systemic lupus erythematosus presenting with sulfonamide hypersensitivity. Brit Med J 1956, 1:1272-1275.
26. Hochberg M.C., Boyd R.E., Ahearn J.M. Systemic lupus erythematosus: a review of clinical laboratory features and genetic markers in 150 patients with emphasis on demographic subsets. Medicine 1985, 64:285-295.
27. Salmon J.E., Roman M.J. Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management. Curr Opin Rheumatol 2001, 13(5):341-344.
28. Atkinson J.P., Schneider P.M. Genetic Susceptibliity and Class III complement genes. Systemic Lupus Erythematosus 1999, 91-104. Academic Press, San Diego. 3rd ed. R.G. Lahita (Ed.).
29. Cook L., Agnello V., Complement Deficiency erythematosus systemic lupus Systemic Lupus Erythematosus 1999, 105-128. Academic Press, San Diego. 3rd ed. R.G. Lahita (Ed.).
30. Urowitz M.B., Gladman D.D. Antinuclear antibody negative lupus. Systemic Lupus Erythematosus 1992, 561-580. Churchill Livingstone, New York. 2nd ed. R.G. Lahita (Ed.).
31. Fernandez S.A., Lobo A.Z., Oliveira Z.N., Fukumori L.M., Pr A.M., Rivitti E.A. Prevalence of antinuclear autoantibodies in the serum of normal blood dornors. Rev Hosp Clin Fac Med Sao Paulo 2003, 58(6):315-319.
32. Tobin D.J., Orentreich N., Bystryn J.C. Autoantibodies to hair follicles in normal individuals. Arch Dermatol 1994, 130(3):395-396.
33. Stollar B.D. The antigenic potential and specificity of nucleic acids, nucleoproteins and their modified derivatives. Arthritis and Rheum 1981, 24:1010-1018.
34. Abu-Shakra M., Krup M., Slor H., Shoenfeld Y. Anti-Sm-RNP activity in sera of patients with rheumatic and autoimmune diseases. Clin Rheumatol 1990, 9:346-355.
35. Tan E.M., Smolen J.S., McDougal J.S., Fritzler M.J., Gordon T., Hardin J.A., et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content. J Rheumatol 2002, 29(1):68-74.
36. van Vugt R.M., Derksen R.H., Kater L., Bijlsma J.W. Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus. Ann Rheum Dis 1998, 57(9):540-544.
37. Lawrence R.C., Hochberg M.C., Kelsey J.L., McDuffie F.C., Medsger T.A., Felts W.R., et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989, 16:427-441.
38. Schofield J.K., Cerio R., Grice K. Systemic lupus erythematosus presenting with 'rheumatoid nodules'. Clin Exp Dermatol 1992, 17(1):53-55.
39. Suarez-Gestal M., Calaza M., Dieguez-Gonzalez R., Perez-Pampin E., Pablos J.L., Navarro F., et al. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. Arthritis Rheum 2009, 60(9):2558-2564.
40. Egol K.A., Jazrawi L.M., De Wal H., Su E., Leslie M.P., Di Cesare P.E. Orthopaedic manifestations of systemic lupus erythematosus. Bull Hosp Jt Dis 2001, 60(1):29-34.
41. Gladman D.D., Urowitz M.B., Chaudhry-Ahluwalia V., Hallet D.C., Cook R.J. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol 2001, 28(4):761-765.
42. Murphy Nancy G., Koolvisoot A., Schumacher H.R., Feldt Joan M., Callegari Peter E. Musculoskeletal features in systemic lupus erythematosus and their relationship with disability [record supplied by Aries Systems]. J Clin Rheumatol 1998, 4(5):238-245.
43. Quismorio F.P., Dubois E.L. Septic arthritis in systemic lupus erythematosus. J Rheum 1975, 2:73-82.
44. Isenberg D. Myositis in other connective tissue diseases. Clinics of Rheumatic Diseases 1984, 10:151-174.
45. Yood R.A., Smith T.W. Iclusion body myositis and systemic lupus erythematosus. J Rheum 1985, 12:568570.
46. Askari A., Vignos P.J., Moskowitz R.W. Steroid myopathy in connective tissue disease. Am J Med 1976, 61:485-492.
47. Casado E., Gratacos J., Tolosa C., Martinez J.M., Ojanguren I., Ariza A., et al. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis 2006, 65(3):385-390.
48. Appel G.B., Silva F.G., Pirani C.L. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine 1978, 57:371.
49. Koffler D., Agnello V., Carr R.I. Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus. Am J Path 1969, 56:305-316.
50. McLaughlin J.R., Bombardier C., Farewell V.T., Gladman D.D., Urowitz M.B. Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables. Arthritis Rheum 1994, 37:559-567.
51. Baldwin D.S., Lowenstein J., Rothfield N.F. The clinical course of the proliferative and membranous forms of lupus. Ann Intern Med 1970, 73:929-942.
52. Gladman D.D., Urowitz D.D., Cole E. Kidney Biopsy in SLE. I. A clinical-morphologic evaluation. Quart J Med 1989, 73:1125-1133.
53. Bajaj S., Albert L., Gladman D.D., Urowitz M.B., Hallett D.C., Ritchie S. Serial renal biopsy in systemic lupus erythematosus. J Rheumatol 2000, 27(12):2822-2826.
54. Yoo C.W., Kim M.K., Lee H.S. Predictors of renal outcome in diffuse proliferative lupus nephropathy: data from repeat renal biopsy. Nephrol Dial Transplant 2000, 15(10):1604-1608.
55. Markowitz G.S., D'Agati V.D. Classification of lupus nephritis. Curr Opin Nephrol Hypertens 2009, 18(3):220-225.
56. Sada K.E., Makino H. Usefulness of ISN/RPS classification of lupus nephritis. J Korean Med Sci 2009, 24(Suppl):S7-10.
57. Platt J.F., Rubin J.M., Ellis J.H. Lupus nephritis: predictive value of conventional and Doppler US and comparison with serologic and biopsy parameters. Radiology 1997, 203(1):82-86.
58. Appel G.B., Radhakrishnan J., Ginzler E.M. Use of mycophenolate mofetil in autoimmune and renal diseases. Transplantation 2005, 80(Suppl. 2):S265-S271.
59. Arias J., Fernandez-Rivas M., Panadero P. Selective fixed drug eruption to amoxycillin. Clin Exp Dermatol 1995, 20(4):339-340.
60. DeFronzo R.A., Cooke C.R., Goldberg M. Impaired renal tubular potassium secretion in systemic lupus erythematosus. Ann Intern Med 1977, 86:268-271.
61. Uwonkunda M.R., Cosyns J.P., Devogelaer J.P., Houssiau F.A. Glomerular thrombosis: an unusual cause of renal failure in systemic lupus erythematosus. Acta Clin Belg 1998, 53(6):371-373.
62. Bhandari S., Harnden P., Brownjohn A.M., Turney J.H. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM 1998, 91(6):401-409.
63. Amend W.J.C., Vincenti F., Feduska N.J. Recurrent systemic lupus erythematosus involving renal allografts. Ann Intern Med 1981, 94:444.
64. Calabrese L.V., Stern T.A. Neuropsychiatric manifestations of systemic lupus erythematosus. Psychosomatics 1995, 36(4):344-359.
65. Feinglass E.J., Arnett F.C., Dorsch C.A. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine 1976, 55:323-339.
66. Harrison M.J., Ravdin L.D. Cognitive dysfunction in neuropsychiatric systemic lupus erythematosus. Curr Opin Rheumatol 2002, 14(5):510-514.
67. Omdal R. Some controversies of neuropsychiatric systemic lupus erythematosus. Scand J Rheumatol 2002, 31(4):192-197.
68. W.J. McCune, J. Golbus, Neuropsychiatric Lupus. Rheum Dis Clin North Am (1988 April) 149-167.
69. Johnson R.T., Richardson E.P. The neurological manifestations of systemic lupus erythematosus. Medicine 1968, 47:337-369.
70. Ozgencil E., Gulucu C., Yalcyn S., Alanoglu Z., Unal N., Oral M., et al. Seizures and loss of vision in a patient with systemic lupus erythematosus. Neth J Med 2007, 65(7):274.
71. Baizabal-Carvallo J.F., Cantu-Brito C., Garcia-Ramos G. Acute neurolupus manifested by seizures is associated with high frequency of abnormal cerebral blood flow velocities. Cerebrovasc Dis 2008, 25(4):348-354.
72. Andrade R.M., Alarcon G.S., Gonzalez L.A., Fernandez M., Apte M., Vila L.M., et al. Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis 2008, 67(6):829-834.
73. Kohen M., Asherson R.A., Gharavi A.E., Lahita R.G. Lupus psychosis: differentiation from the steroid-induced state. Clin Exp Rheumatol 1993, 11:323-326.
74. Bonfa E., Golombek S.J., Kaufman L.D. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Eng J Med 1987, 317:265-271.
75. Penn A.S., Rowan A.J. Myelopathy in systemic lupus erythematosus. Archives of Neurology 1968, 18:337-349.
76. Fulford K.W.M., Catterall R.D., Delhanty J.J., Doniach D., Kremer M. A collagen disorder of the nervous system presenting as multiple sclerosis. Brain 1972, 95:373-386.
77. Levine S.R., Welch K.M.A. The spectrum of neurologic disease associated with anti-phospholipid antibodies. Archives of Neurology 1987, 44:876-883.
78. Lavalle C., Pizarro S., Drenkard C. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheum 1990, 17:34-37.
79. Futrell N., Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke 1989, 20:583-591.
80. Ginsburg K.S., Liang M.H., Newcomer L., Golhaber S.Z., Schur P.H., Hennekens C.H. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992, 117:997-1002.
81. Groothuis J.R., Groothuis D.R., Mukhopadhyay D. Lupus associated chorea in childhood. Am J Dis Child 1977, 131:1131-1134.
82. Lahat E., Eshel G., Azizi E. Chorea associated with systemic lupus erythematosus in children: a case report. Israel J Med Sci 1989, 25:568-570.
83. Brechnian B. CNS Lupus. Clin Rheum Dis 1982, 8:183-192.
84. Jara L.J., Vera-Lastra O., Miranda J.M., Alcala M., Alvarez-Nemegyei J. Prolactin in human systemic lupus erythematosus. Lupus 2001, 10(10):748-756.
85. Hellmann D.B., Laing T.J., Petri M. Mononeuritis multiplex: the yield of evaluations for occult rheumatic diseases. Medicine 1988, 67:145-153.
86. Simpson J.A. Peripheral neuropathy: etiological and clinical aspects. Proc R Soc Med 1971, 64(3):291-293.
87. Small P., Mass M.F., Kohler P.T. Central nervous system involvement in systemic lupus erythematosus, Diagnostic profile and clinical features. Arth Rheum 1977, 20:869-878.
88. Lass P., Koseda M., Lyczak P. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with central nervous system involvement. J Nucl Med 1998, 39(5):930-931.
89. Sibbit W.L., Sibbit R.R., Griffey R.H. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in SLE. Annals of Rheumatic Disease 1989, 48:1014-1022.
90. Kowal C., Degiorgio L.A., Lee J.Y., Edgar M.A., Huerta P.T., Volpe B.T., et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA 2006, 103(52):19854-19859.
91. Petri M. Systemic lupus erythematosus and the heart. Systemic Lupus Erythematosus 1999, 687-706. Academic Press, San Diego. 3rd ed. R.G. Lahita (Ed.).
92. Lemos J., Santos L., Martins I., Nunes L., Santos O., Henriques P. Systemic lupus erythematosus - a diagnosis in cardiology. Rev Port Cardiol 2008, 27(6):841-849.
93. Cohen A.S., Canoso J.J. Pericarditis in the rheumatologic diseases. Cardiovasc Clin 1976, 7(3):237-255.
94. Knockaert D.C. Cardiac involvement in systemic inflammatory diseases. Eur Heart J 2007, 28(15):1797-1804.
95. Chang R.W. Cardiac manifestations of SLE. Clin Rheum Dis 1982, 8(1):197-206.
96. Kalashnikova L.A., Nasonov E.L., Borisenko V.V., Usman V.B., Prudnikova L.Z., Kovaljov V.U., et al. Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol 1991, 9(4):357-361.
97. Hierro F.R., Corretger J.M. [Cardiovascular manifestations of children's collagenosis (author's transl)]. An Esp Pediatr 1981, 15(1):75-81.
98. Bayraktar Y., Tanaci N., Egesel T., Gokoz A., Balkanci F. Antiphospholipid syndrome presenting as portopulmonary hypertension. J Clin Gastroenterol 2001, 32(4):359-361.
99. Hogarth M.B., Judd L., Mathias C.J., Ritchie J., Stephens D., Rees R.G. Cardiovascular autonomic function in systemic lupus erythematosus. Lupus 2002, 11(5):308-312.
100. Astorri E., Fiorina P., Contini G.A., Albertini D., Ridolo E., Dall'Aglio P. Diastolic impairment in asymptomatic systemic lupus erythematosus patients. Clin Rheumatol 1997, 16(3):320-321.
101. Kasparian A., Floros A., Gialafos E., Kanakis M., Tassiopoulos S., Kafasi N., et al. Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 2007, 16(7):505-508.
102. Pope J.E. The diagnosis and treatment of Raynaud's phenomenon: a practical approach. Drugs 2007, 67(4):517-525.
103. Wierzbicki A.S. Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus. Lupus 2000, 9(3):194-201.
104. Aranow C., Ginzler E.M. Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 2000, 9(3):166-169.
105. Svenungsson E., Jensen-Urstad K., Heimburger M., Silveira A., Hamsten A., de Faire U., et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001, 104(16):1887-1893.
106. Hahn B.H., McMahon M. Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies. Lupus 2008, 17(5):368-370.
107. McMahon M., Hahn B.H. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association. Curr Opin Immunol 2007, 19(6):633-639.
108. McMahon M., Grossman J., Skaggs B., Fitzgerald J., et al. Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arth Rheum 2009, 60(8):2428-2437.
109. Marchesoni A., Messina K., Carrieri P. Pulmonary hypertension and systemic lupus erythematosus. Clin Exp Rheum 1983, 1:24-250.
110. Onomura K., Nakata H., Tanaka Y., Tsuda T. Pulmonary hemorrhage in patients with systemic lupus erythematosus. J Thorac Imaging 1991, 6:57-61.
111. Orens J.B., Martinez F.J. Lynch JP3. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1994, 20:159-193.
112. Callejas-Rubio J.L., Lopez-Perez L., Moreno-Escobar E., Ortego-Centeno N. Raynaud's phenomenon and pulmonary arterial hypertension. Lupus 2008, 17(4):355.
113. Dalcin P.T., Barreto S.S., Cunha R.D., Xavier R.M., Brenol J.C., Marroni B.J. Lung clearance of 99mTc-DTPA in systemic lupus erythematosus. Braz J Med Biol Res 2002, 35(6):663-668.
114. Franks T.J., Koss M.N. Pulmonary capillaritis. Curr Opin Pulm Med 2000, 6(5):430-435.
115. Zandman-Goddard G., Ehrenfeld M., Levy Y., Tal S. Diffuse alveolar hemorrhage in systemic lupus erythematosus. Isr Med Assoc J 2002, 4(6):470.
116. Hughson M.D., He Z., Henegar J., McMurray R. Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus. Arch Pathol Lab Med 2001, 125(4):475-483.
117. Wilcox P.G., Stein H.B., Clarke S.D. Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus. Chest 1988, 93:352-358.
118. Cheng T.O. Pulmonary hypertension in systemic lupus erythematosus. Mayo Clin Proc 1999, 74(8):845.
119. Shapiro S., Long M. Hematology: coagulation problems. Systemic Lupus Erythematosus 1999, 871-886. Academic Press, San Diego. 3rd ed. R.G. Lahita (Ed.).
120. Simantov R., Laurence J., Nachman R. The cellular hematology of systemic lupus erythematosus. Systemic Lupus Erythematosus 1999, 765-792. Academic Press, San Diego. 3rd ed. R.G. Lahita (Ed.).
121. Laurence J., Wong J.E.L., Nachman R. The cellular hematology of systemic lupus erythematosus. Systemic Lupus Erythematosus 1992, 771-806. Churchill Livingstone, New York. 2nd ed. R.G. Lahita (Ed.).
122. Cines D.B., Liebman H., Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol 2009, 46(1 Suppl. 2):S2-14.
123. Pierrot-Deseilligny D.C., Michel M., Khellaf M., Gouault M., Intrator L., Bierling P., et al. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Br J Haematol 2008, 142(4):638-643.
124. Erkan D., Yazici Y., Lockshin M.D. Lupus anticoagulant-hypoprothrombinemia syndrome and pregnancy. Lupus 2001, 10(4):311-312.
125. Joseph R.E., Radhakrishnan J., Appel G.B. Antiphospholipid antibody syndrome and renal disease. Curr Opin Nephrol Hypertens 2001, 10(2):175-181.
126. Zecevic R.D., Vojvodic D., Ristic B., Pavlovic M.D., Stefanovic D., Karadaglic D. Skin lesions - an indicator of disease activity in systemic lupus erythematosus?. Lupus 2001, 10(5):364-367.
127. Blaszczyk M., Jablonska S., Chorzelski T.P., Jarzabek-Chorzelska M., Beutner E.H., Kumar V. Clinical relevance of immunologic findings in cutaneous lupus erythematosus. Clin Dermatol 1992, 10:399-406.
128. Gammon W.R., Fine J.D., Forbes M., Briggaman R.A. Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 1992, 27(1):79-87.
129. Gilliam J. Systemic lupus erythematosus and the skin. Systemic Lupus Erythematosus 1987, 616-650. Wiley, New York. 1st ed. R.G. Lahita (Ed.).
130. Golan T.D., Gharavi A.E., Elkon K.B. Penetration of autoantibodies into living epithelial cells. J Invest Dermatol 1993, 100:316-322.
131. Provost T.T., Arnett F., Reichlin M. C2 deficiency, lupus erythematosus and anticytoplasmic Ro (SSA antibodies). Arth Rheum 1983, 26:1279-1282.
132. Sultan S.M., Ioannou Y., Isenberg D.A. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 1999, 38(10):917-932.
133. Tatelman M., Keech M.K. Esophageal motililty in systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Radiology 1966, 86:1041-1046.
134. Chng H.H. Lupus the great mimic: gastrointestinal manifestations. Singapore Med J 2001, 42(8):342-345.
135. Hallegua D.S., Wallace D.J. Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheumatol 2000, 12(5):379-385.
136. Lee C.K., Ahn M.S., Lee E.Y., Shin J.H., Cho Y.S., Ha H.K., et al. Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis 2002, 61(6):547-550.
137. Luman W., Chua K.B., Cheong W.K., Ng H.S. Gastrointestinal manifestations of systemic lupus erythematosus. Singapore Med J 2001, 42(8):380-384.
138. Baron M., Brisson M.L. Pancreatitis in systemic lupus erythematosus. Arth Rheum 1982, 25:1006-1009.
139. Koh M.S., Sunil K., Howe H.S. Late onset systemic lupus erythematosus with elevated CA125 and gastrointestinal ischaemia. Intern Med J 2002, 32(3):117-118.
140. Pollack V.E., Grove W.J., Karkin R.M. Systemic lupus erythematosus simulating acute surgical condition of the abdomen. N Eng J Med 1958, 259:258-266.
141. Salomon P., Mayer L. Non-hepatic gastrointestinal manifestations of systemic lupus erythematosus. Systemic Lupus Erythematosus 1992, 747-760. Churchill Livingstone, New York. 2nd ed. R.G. Lahita (Ed.).
142. Bearn A.G., Kunkel H.G., Slater R.J. The problem of chronic liver disease in young women. Am J Med 1956, 21:3-15.
143. Seaman W.E., Plotz P.H. Effect of aspirin on liver tests in patients with RA or SLE and in normal volunteers. Arth Rheum 1976, 19:155-160.
144. Gold D.H., Morris D.A., Henkind P. Ocular findings in systemic lupus erythematosus. Brit J Opthalmol 1972, 56:800-804.
145. Stafford-Brady F., Urowitz M.B., Gladman D.D. Lupus retinopathy. Arth Rheum 1988, 31:1105-1110.
146. Wong K., Everett A., Verier-Jones J. Visual loss as the initial symptom of systemic lupus erythematosus. Am J Opthalmol 1981, 92:238-244.
147. Rosenbaum J.T., Wernick R. The utility of routine screening of patients with uveitis for systemic lupus erythematosus or tuberculosis. A Bayesian analysis. Archives of Opthalmology 1990, 108:1291-1293.
148. Harari S., Paciocco G., Aramu S. Ear and nose involvement in systemic diseases. Monaldi Arch Chest Dis 2000, 55(6):466-470.
149. Kastanioudakis I., Ziavra N., Voulgari P.V., Exarchakos G., Skevas A., Drosos A.A. Ear involvement in systemic lupus erythematosus patients: a comparative study. J Laryngol Otol 2002, 116(2):103-107.